| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $171K | -3.9% |
| Cost of Revenue | $242K | -12.3% |
| Gross Profit | -$71K | +27.6% |
| R&D Expense | $4.9M | +25.6% |
| SG&A Expense | $7.0M | +11.5% |
| Operating Income | -$10.0M | +1.8% |
| Interest Expense | $3K | +0.0% |
| Net Income | -$10.0M | -0.5% |
| EPS (Basic) | -$0.63 |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | +18.2% |
| Short-term Investments | $3.0M | — |
| Accounts Receivable | $33K | -31.2% |
| Inventory | $705K | +616.8% |
| Current Assets | $12.2M | +67.0% |
| Total Assets | $12.8M | +61.5% |
| Current Liabilities | $3.1M | +162.2% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | +12.6% |
| Capital Expenditures | $275K | +310.3% |
| Investing Cash Flow | -$3.2M | -4737.2% |
| Financing Cash Flow | $12.0M | +4.2% |
| Free Cash Flow | -$7.8M | +10.1% |
| +32.3% |
| EPS (Diluted) | -$0.63 | +32.3% |
| Long-term Debt |
| $120K |
| -41.1% |
| Total Liabilities | $3.2M | +132.4% |
| Stockholders' Equity | $9.6M | +46.5% |